Almac Group Collaborates with Exostar to Extend Clinical Trials Identity Management
eClinical Application Users Benefit from Single Sign-On Expediency & Enhanced Security
Souderton, PA., 15 December 2016 – Almac Clinical Technologies, part of the Almac Group, the world’s largest privately-held contract pharmaceutical development and manufacturing organisation, today announced a collaboration with Exostar, whose cloud-based solutions help companies in highly-regulated industries mitigate risk and solve their identity and access challenges. The companies are working together to provide Single Sign-On (SSO) and Federated-Authentication access to eClinical applications used to support clinical trials, including Interactive Response Technology (IRT).